David F. Penson

1 month ago | oncodaily.com | Kate Dwyer |David F. Penson |Ruchika Talwar

Ruchika Talwar, Medical Director, Office of Episodes of Care, Population Health at Vanderbilt University Medical Center, shared a post on X:“Thrilled to share this labor of love just published in Journal of Clinical Oncology exploring drivers behind cancer drug shortages and proposing actionable solutions.”“Drug Shortages Demand Action: Policy Changes to Protect Patient Care“Authors: Brian D. Cortese, Kate Dwyer, Lan Anh S. Galloway, David F.

Mar 11, 2024 | urotoday.com | David F. Penson

Read the Full Video TranscriptSam Chang: Hi, my name is Sam Chang, and I am a urologist in Nashville, Tennessee, and I work under probably one of the best bosses in America, and he's with us today. He needs no introduction, but Dr. David Penson, the Chair of Urology at Vanderbilt, is also now the secretary of the AUA.

May 9, 2023 | urotoday.com | David F. Penson

Read the Full Video TranscriptAlicia Morgans: Hi, I am so excited to be here with Professor David Penson who's joining us as the Professor and Chair of Urology at Vanderbilt University Medical Center. Thank you so much for being here with me today, David. David Penson: Thanks, Alicia. It's always good to talk to you. Alicia Morgans: It's always good to talk to you too.

May 9, 2023 | urotoday.com | David F. Penson

In this conversation, Alicia Morgans speaks with Professor David Penson about the ProtecT trial and its implications for clinical practice. The study found no difference in outcomes between surgery, radiation, and conservative management in prostate cancer patients after 10 years of follow-up. However, a recent 15-year follow-up has revealed some new findings.